Scandinavian Journal of Trauma Resuscitation and Emergency Medicine· 2026Q1
Gelatin 4% and hydroxyethyl starch (130/0.42) impair clot formation in a human ex vivo whole-blood resuscitation model
- 0citations
- Q1SCImago
- 2026year
Short summary
Gelatin 4% and hydroxyethyl starch (HES 130/0.42) significantly impair clot formation in human whole blood ex vivo, with HES showing the most pronounced negative effect.
AI-generated from the title and abstract; the full text is not read.
Key points
- Gelatin 4% and HES 130/0.42 significantly reduced clot formation and firmness in human whole blood ex vivo.
- HES 130/0.42 exhibited a more pronounced hypocoagulable profile than gelatin.
- The adverse effects on clot formation were ratio-dependent and not solely due to dilution.
- Platelet activation, thrombin-antithrombin complexes, and complement markers remained unchanged.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Background Colloid solutions provide effective intravascular volume expansion but can impair hemostasis, which is particularly critical after trauma-associated hemorrhagic shock. The differential effects of specific colloids on plasmatic coagulation, platelet function and complement activation, especially when used alongside crystalloids, are still underexplored. We therefore examined graded hemodilution with gelatin or hydroxyethyl starch, alone and in combination with a balanced crystalloid, in an ex vivo human whole-blood model over time. Methods We used a citrate- and heparin-free human ex vivo whole-blood model to assess the effects of volume dilution with a balanced crystalloid (Jonosteril), gelatin solution (Gelafundin 4%) and hydroxyethyl starch (HES 130/0.42, 6%; Tetraspan). Whole-blood was diluted at increasing ratios up to 4:6 (diluent:blood), incubated for 30 minutes at 37 °C and analyzed for blood gases, standard coagulation tests, platelet activation (CD62P), von Willebrand factor (vWF), thrombin–antithrombin complexes, complement activation and viscoelastic parameters by ROTEM (EXTEM, INTEM, FIBTEM). Results At high dilution ratios, colloid-diluted samples exhibited more frequent macroscopic clotting and significantly lower pH with more pronounced base deficit than Jonosteril. Gelafundin, but not Jonosteril or Tetraspan, increased vWF levels over time, while CD62P expression, thrombin-antithrombin complexes and complement markers remained unchanged. ROTEM revealed a clearly hypocoagulable profile after dilution with Gelafundin or Tetraspan, most pronounced with HES, with prolonged clotting time and clot formation time, reduced a-angle and maximum clot firmness. When combining Jonosteril with increasing colloid fractions at fixed dilution, these changes followed a non-linear, ratio-dependent pattern. Conclusion Balanced colloids, particularly HES 130/0.42, exert intrinsic, ratio-dependent adverse effects on clot formation beyond simple dilution, suggesting that hemostatic safety may depend not only on fluid type but also on the tolerated proportion of colloid within resuscitation strategies.
The authors' abstract, as published at the source. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Critical Care and Intensive Care Medicine
Critical Care and Intensive Care MedicineMedicine